John B. Russell
Plus aucun poste en cours
Profil
John B.
Russell is the founder of JBR Business Solutions LLC, which is founded in 2010, where he holds the title of President.
He previously worked as an Accounting Manager at Scios, Inc. from 2003 to 2005, as a Controller at inSilicon Corp from 2000 to 2001, and as an Auditor at PricewaterhouseCoopers LLP from 1995 to 2000.
He also held the position of Chief Financial Officer & Treasurer at Koffee Korner, Inc. in 2014 and at Cardax Pharma, Inc. from 2013 to 2015.
Additionally, he was a Controller at Foundries Holdings, Inc. from 2001 to 2002.
Mr. Russell's education history includes an undergraduate degree from Claremont McKenna College.
Postes actifs de John B. Russell
| Sociétés | Poste | Début |
|---|
Anciens postes connus de John B. Russell
| Sociétés | Poste | Fin |
|---|---|---|
Cardax Pharmaceuticals, Inc.
 Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Directeur Financier/CFO | 01/12/2015 |
Cardax Pharma, Inc.
 Cardax Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Cardax, Inc., Cardax Pharma, Inc. is a pharmaceutical company that previously focused on developing a platform of proprietary, exceptionally safe, small molecule compounds for large unmet medical needs where oxidative stress and inflammation play key causative roles. The company is based in Honolulu, HI. The company may seek to monetize its pharmaceutical assets through licensing or sale. Astaxanthin use is supported by hundreds of peer-reviewed papers published in leading medical research journals. The company was founded by David G. Watumull, Samuel F. Lockwood, and David G. Watumull has been the CEO since incorporation. Cardax Pharma was acquired by Koffee Korner, Inc. on February 07, 2014 for $15 million. | Directeur Financier/CFO | 01/12/2015 |
Koffee Korner, Inc.
 Koffee Korner, Inc. Specialty StoresRetail Trade Koffee Korner, Inc. engages in retailing of coffee. The company purchases and roasts high quality whole bean coffees that it sells, along with handcrafted coffee and tea beverages and a variety of fresh food items, through its retail store in Houston, Texas. It products include coffee, tea, ice cream shake and javaccino. The company was founded on July 7, 2003 and is headquartered in Washington Boro, PA. | Directeur Financier/CFO | 21/02/2014 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Comptroller/Controller/Auditor | 01/01/2005 |
Foundries Holdings, Inc.
 Foundries Holdings, Inc. Investment ManagersFinance Foundries Holdings, Inc. operates as a private equity firm. It specializes in providing incubation services for networking and optical startups, includes broadband, wireless and B2B e-commerce. The company was founded by Saiyed Atiq Raza in 1999 and is headquartered in San Jose, CA. | Comptroller/Controller/Auditor | 01/01/2002 |
Formation de John B. Russell
| Claremont McKenna College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARDAX, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
inSilicon Corp
 inSilicon Corp SemiconductorsElectronic Technology Part of Synopsys, Inc., inSilicon Corp provides communications semiconductor intellectual property for semiconductor and system companies. The company is based in San Jose, CA. The company was founded by Barry Hoberman. inSilicon was acquired by Synopsys, Inc. on September 20, 2002 for $61.55 million. | Electronic Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
Koffee Korner, Inc.
Koffee Korner, Inc. Specialty StoresRetail Trade Koffee Korner, Inc. engages in retailing of coffee. The company purchases and roasts high quality whole bean coffees that it sells, along with handcrafted coffee and tea beverages and a variety of fresh food items, through its retail store in Houston, Texas. It products include coffee, tea, ice cream shake and javaccino. The company was founded on July 7, 2003 and is headquartered in Washington Boro, PA. | Retail Trade |
Cardax Pharmaceuticals, Inc.
Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Health Technology |
Cardax Pharma, Inc.
Cardax Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Cardax, Inc., Cardax Pharma, Inc. is a pharmaceutical company that previously focused on developing a platform of proprietary, exceptionally safe, small molecule compounds for large unmet medical needs where oxidative stress and inflammation play key causative roles. The company is based in Honolulu, HI. The company may seek to monetize its pharmaceutical assets through licensing or sale. Astaxanthin use is supported by hundreds of peer-reviewed papers published in leading medical research journals. The company was founded by David G. Watumull, Samuel F. Lockwood, and David G. Watumull has been the CEO since incorporation. Cardax Pharma was acquired by Koffee Korner, Inc. on February 07, 2014 for $15 million. | Health Technology |
Foundries Holdings, Inc.
Foundries Holdings, Inc. Investment ManagersFinance Foundries Holdings, Inc. operates as a private equity firm. It specializes in providing incubation services for networking and optical startups, includes broadband, wireless and B2B e-commerce. The company was founded by Saiyed Atiq Raza in 1999 and is headquartered in San Jose, CA. | Finance |